MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Guidant's Dollens to Retire

Article-Guidant's Dollens to Retire

Originally Published MX July/August 2004



Guidant Corp. (Indianapolis) announced at its annual shareholders meeting in May that president and CEO Ronald W. Dollens will retire in December. Dollens has held the position of CEO since the cardiology company's initial public offering in 1994. Guidant split off from Eli Lilly and Co. (Indianapolis) in 1995.

In a statement, Dollens said that his decision to retire was part of a deliberate, long-term succession plan. The decision, he said, "comes at a time when the company is well positioned to continue its remarkable record of success. I am confident that this management team will continue to advance our outstanding clinical leadership, sustained focus on innovation, and leadership in the public policy arena."


According to Guidant chairman James M. Cornelius, a new CEO will be named by the end of the year. "Under Ron's leadership, Guidant has achieved phenomenal growth and success over the past decade," said Cornelius. "Ron has built a global organization with exceptional intellectual and operational capabilities."

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.